Narcolepsy

Key Points On Narcolepsy

• Narcolepsy is a long-term neurological condition that disrupts the brain's control over sleep-wake cycles, leading to overwhelming daytime sleepiness and, in some cases, sudden muscle weakness triggered by emotions.

• The condition is primarily caused by the loss of specific brain cells that produce a chemical called hypocretin, which is essential for staying awake and regulating sleep. This loss is thought to be the result of an autoimmune reaction.

• Diagnosis involves a detailed medical history and specialized sleep studies, such as an overnight polysomnogram followed by a Multiple Sleep Latency Test (MSLT), to measure how quickly you fall asleep during the day.

• While there is no cure, narcolepsy is a manageable condition. Treatment combines lifestyle adjustments, such as scheduled naps, with medications to improve alertness and control symptoms like cataplexy.

An Overview of Narcolepsy

Narcolepsy is a chronic neurological disorder that affects the central nervous system's capacity to regulate stable periods of sleep and wakefulness (Maski & Guilleminault, 2022).

It belongs to a category of sleep disorders known as central disorders of hypersomnolence. These disorders are characterized by a persistent and sometimes overpowering need to sleep during the day (Maski & Scammell, 2022). Narcolepsy can profoundly affect a person's thinking, concentration, and memory. It also introduces considerable safety concerns, such as a higher risk of motor vehicle accidents, making its diagnosis and management very important (Maski & Scammell, 2022).

But what exactly is happening in the brain to cause this condition?

What Is Narcolepsy Type 1 & Narcolepsy Type 2?

Narcolepsy is a disorder that fundamentally blurs the lines between being awake and being asleep. The official classification system for sleep disorders, the ICSD-3, recognizes two main types.

• Narcolepsy Type 1 (NT1): This type is defined by the presence of excessive daytime sleepiness along with cataplexy—a sudden, brief loss of muscle control. NT1 is caused by a deficiency of a neuropeptide, which is a type of chemical messenger in the brain (Mignot, 2022).

• Narcolepsy Type 2 (NT2): This type involves excessive daytime sleepiness but without cataplexy. The underlying causes of NT2 are less understood and can vary from person to person (Mignot, 2022).

So, just how many people are living with this condition?

How Common Is Narcolepsy?

Narcolepsy is a relatively rare condition, affecting about 0.02% to 0.06% of people in most parts of the world (Mignot, 2022; Maski & Guilleminault, 2022). The number of new cases of NT1 diagnosed each year is estimated to be between 0.5 and 1 for every 100,000 people (Mignot, 2022). The disorder appears to affect men and women in equal numbers (Maski & Guilleminault, 2022).

The age when symptoms first appear usually begins in one of two main age ranges. The most common time for onset is between the ages of 10 and 25, with a smaller peak occurring later, between 35 and 45 years old (Mignot, 2022; Maski & Guilleminault, 2022). Interestingly, a significant increase in new cases was observed after the 2009 H1N1 influenza pandemic, particularly in children in Northern Europe who received a specific type of H1N1 vaccine, which highlighted a link between environmental factors and the immune system in triggering the disorder (Mignot, 2022; Maski & Guilleminault, 2022).

This connection to the immune system points toward the underlying causes of the disorder. What are the specific factors that lead to its development?

What Causes Narcolepsy? What Are the Risks That Make It More Likely?

The primary cause of narcolepsy type 1 (NT1) is the destruction of a small group of neurons, or brain cells, in a part of the brain called the hypothalamus. These cells are responsible for producing chemicals called hypocretins (also known as orexins), which are critical for regulating wakefulness. NT1 is understood to be an autoimmune disease, where the body's own T-cells—a type of immune cell—mistakenly attack and destroy these essential hypocretin-producing neurons (Mignot, 2022). For narcolepsy type 2 (NT2), the cause is not as clear, as individuals with NT2 usually have normal levels of hypocretin (Mignot, 2022).

Several risk factors are known to be involved, particularly for NT1:

• Genetic Susceptibility: A strong genetic link exists. About 97% of people with NT1 carry a specific gene variation known as HLA-DQB1*06:02 (Mignot, 2022). Other genes related to the T-cell receptor, which helps the immune system identify threats, also contribute to the risk (Mignot, 2022). However, genetics are not the whole story; the chance of an identical twin also having narcolepsy if their sibling has it is only 25% to 30%, which shows that other factors must be involved (Mignot, 2022).

• Environmental Triggers: Infections in the upper airway are strongly associated with the onset of narcolepsy. The H1N1 influenza A virus and Streptococcus pyogenes (the bacterium that causes strep throat) have been identified as significant triggers (Mignot, 2022). The leading theory is a process called molecular mimicry, where the immune system, in fighting off the infection, creates T-cells that not only recognize the virus but also mistakenly cross-react with the hypocretin brain cells, leading to their destruction (Mignot, 2022).

With these causes in mind, what are the specific symptoms someone with narcolepsy might experience?

What Are the Signs And Symptoms of Narcolepsy?

The symptoms of narcolepsy are often grouped into a classic set of five symptoms. Not everyone will experience all five.

1. Excessive Daytime Sleepiness (EDS): This is the universal symptom experienced by everyone with narcolepsy. It involves a constant feeling of drowsiness and may lead to "sleep attacks," which are sudden, uncontrollable urges to sleep. These episodes can result in short naps that are often, but only temporarily, refreshing (Maski & Guilleminault, 2022).

2. Cataplexy: This symptom is the defining feature of NT1. Cataplexy is a sudden and temporary loss of muscle control, typically triggered by strong, positive emotions like laughter, joy, or surprise (Maski & Guilleminault, 2022). It can range from a slight drooping of the eyelids to a complete collapse of the body. In children, cataplexy can look different, sometimes appearing as a slack jaw, tongue protrusion, or unusual motor tics without a clear emotional trigger (Maski & Guilleminault, 2022; Sahni & Attarian, 2022).

3. Sleep Paralysis: This is a temporary inability to move or speak that occurs just as a person is falling asleep or waking up. It can be a frightening experience but is generally brief.

4. Hypnagogic and Hypnopompic Hallucinations: These are vivid, dream-like experiences that can be frightening and seem very real. Hypnagogic hallucinations happen while falling asleep, and hypnopompic hallucinations happen while waking up.

5. Disrupted Nighttime Sleep: Despite being extremely sleepy during the day, many people with narcolepsy have fragmented and poor-quality sleep at night.

Both sleep paralysis and hallucinations are thought to be caused by features of rapid eye movement (REM) sleep - the stage of sleep where most dreaming occurs - intruding into a state of wakefulness (Maski & Guilleminault, 2022).

Given these distinct symptoms, how does a doctor confirm a diagnosis?

How is Narcolepsy Diagnosed?

Diagnosing narcolepsy requires a careful evaluation that includes a detailed clinical history of the patient's symptoms combined with objective medical tests.

The first step is usually an overnight sleep study called a polysomnogram (PSG). This test records various body functions during sleep, such as brain waves, eye movements, and breathing. Its main purpose is to rule out other sleep disorders, like sleep apnea, that could be causing the daytime sleepiness (Maski & Guilleminault, 2022).

The day after the overnight study, the patient undergoes a Multiple Sleep Latency Test (MSLT). During the MSLT, the patient is asked to take five scheduled naps, separated by two-hour breaks. The test measures how long it takes the person to fall asleep (known as sleep latency) and how quickly they enter REM sleep. A diagnosis of narcolepsy is confirmed if the test shows:

• An average sleep-onset latency of 8 minutes or less across the five naps.

• The presence of two or more sleep-onset REM periods (SOREMPs), which means the person entered REM sleep shortly after falling asleep (Maski & Guilleminault, 2022).

For NT1, there is another highly specific diagnostic test. This involves taking a sample of cerebrospinal fluid (CSF) via a lumbar puncture (also known as a spinal tap) to measure the level of hypocretin-1. A level at or below 110 pg/mL is a definitive marker for NT1 (Mignot, 2022; Maski & Guilleminault, 2022).

Beyond the main symptoms, are there other health issues associated with the condition?

What Are Common Health Problems Linked to Narcolepsy?

Because the hypocretin system influences not just sleep but also metabolism, mood, and other functions, narcolepsy is linked to a high rate of other health conditions, known as comorbidities.

• Obesity: Rapid and significant weight gain is common, especially in children around the time their symptoms start. This weight gain often happens because of a lower basal metabolic rate, which is the rate at which the body burns calories while at rest, not just because of changes in eating habits (Maski & Guilleminault, 2022; Sahni & Attarian, 2022).

• Precocious Puberty: As many as 17% of children with NT1 experience puberty at an unusually early age. This is thought to be related to the loss of hypocretin's influence on the hormones that control development (Maski & Guilleminault, 2022; Sahni & Attarian, 2022).

• Psychiatric Conditions: Depression and anxiety are common among people with narcolepsy. Additionally, symptoms that look like attention-deficit/hyperactivity disorder (ADHD) are common (Maski & Guilleminault, 2022; Sahni & Attarian, 2022).

• Other Sleep Disorders: It is not uncommon for individuals with narcolepsy to also suffer from other sleep disorders, such as obstructive sleep apnea (OSA), periodic limb movements of sleep, and REM sleep behavior disorder (Maski & Guilleminault, 2022).

These health issues contribute to the broader challenges of the disorder. How does narcolepsy impact a person's day-to-day life?

How Does Narcolepsy Affect Daily Life?

The impact of narcolepsy on a person's life can be substantial, affecting personal, social, and economic well-being. The condition can significantly reduce a person's quality of life, limit career opportunities, and harm school performance (Maski & Guilleminault, 2022).

For young people, the effects can be particularly difficult. Teenagers with narcolepsy tend to miss more school, achieve lower grades, and participate in fewer extracurricular activities compared to their peers (Sahni & Attarian, 2022). From an economic standpoint, the disorder leads to higher healthcare costs, more workplace accidents, and increased rates of job loss, short-term disability, and early retirement (Maski & Guilleminault, 2022).

With such a significant impact, what can be done to manage the condition?

How Is Narcolepsy Treated?

While there is currently no cure for narcolepsy, its symptoms can be effectively managed with a combination of behavioral strategies and medication, which is also known as pharmacotherapy.

Behavioral and Lifestyle Adjustments These non-medical approaches are a foundational part of treatment:

• Scheduled Naps: Planning one or two short naps of 15 to 30 minutes during the day can help manage sleepiness.

• Consistent Sleep Schedule: Maintaining a strict sleep-wake schedule, even on weekends, helps regulate the body's internal clock.

• Good Sleep Hygiene: This includes creating a comfortable sleep environment and avoiding caffeine or alcohol close to bedtime.

• Accommodations: Securing formal accommodations at school or in the workplace, such as adjusted schedules or designated nap times, is very important.

Medications are prescribed to target specific symptoms (not all medications are available across countries):

• For Excessive Daytime Sleepiness (EDS): The first-line treatments are wake-promoting agents like modafinil and armodafinil. Newer options include pitolisant and solriamfetol, which can improve alertness with fewer side effects than traditional stimulants (Maski & Guilleminault, 2022). Traditional stimulants like amphetamines and methylphenidate are also effective but have a higher risk of tolerance and other side effects (Maski & Guilleminault, 2022).

• For Cataplexy and Disrupted Sleep: Sodium oxybate is a highly effective medication that improves the quality of nighttime sleep, which in turn reduces both cataplexy and daytime sleepiness (Maski & Guilleminault, 2022). Antidepressants, such as SSRIs and SNRIs (like venlafaxine), are also commonly used to control cataplexy by suppressing REM sleep (Maski & Guilleminault, 2022).

It is important to be aware of potential side effects. For example, modafinil can cause headaches and anxiety, while sodium oxybate carries risks that require careful monitoring through a restricted program (Maski & Guilleminault, 2022).

What are some practical ways to put these management strategies into practice?

Tips for Living Well With Narcolepsy

Living with a chronic condition like narcolepsy means taking an active role in your treatment and learning to speak up for your needs. Here are some practical tips to help manage the condition effectively:

• Prioritize Your Sleep Schedule: Treat your sleep schedule as a prescription. Go to bed and wake up at the same time every day, and schedule your naps as you would any other important appointment.

• Educate Others: Help your family, friends, teachers, and employers understand your condition. Explaining what narcolepsy is and how it affects you can build a strong support system and make it easier to get the accommodations you need.

• Join a Support Group: Connecting with others who have narcolepsy can be incredibly helpful. Groups like the Narcolepsy Network provide a community for sharing experiences and coping strategies (Maski & Guilleminault, 2022).

• Practice Self-Advocacy: Don't be afraid to ask for what you need, whether it's a 20-minute nap break at work or extended time on an exam at school.

• Stay Active: Regular physical activity can improve sleep quality and overall well-being, but try to avoid exercising too close to bedtime.

• Be Mindful of Diet: Pay attention to how certain foods affect your sleepiness. Heavy meals can worsen drowsiness, while a balanced diet can help maintain stable energy levels.

When should someone seek out a medical professional for these issues?

When to Get Professional Help for Narcolepsy

You should consider seeking professional help from a doctor or a medical sleep specialist if you or your child consistently experience any of the core symptoms of narcolepsy. It is particularly important to make an appointment if you notice:

• Persistent and overwhelming sleepiness during the day that interferes with school, work, or social activities.

• Episodes of muscle weakness or collapse that seem to be triggered by emotions like laughter.

• Frightening experiences of being unable to move when falling asleep or waking up.

• Vivid, dream-like hallucinations around the time of sleep.

Early diagnosis and intervention are key to managing symptoms, preventing academic or professional setbacks, and ensuring safety.

NOTE: The Better Sleep Clinic is a behavioural sleep medicine clinic and cannot diagnose or offer first line medication treatments. We can provide adjunctive treatments such as CBT-h that help manage depression, anxiety and day-to-day life management.

Key Takeaways About Narcolepsy

• Narcolepsy is a lifelong neurological condition that disrupts the normal boundaries between sleep and wakefulness.

• The most common form, Narcolepsy Type 1, is an autoimmune disorder caused by the destruction of brain cells that produce a wakefulness-promoting chemical called hypocretin.

• Its main symptoms include excessive daytime sleepiness, cataplexy (in NT1), sleep paralysis, hallucinations, and disrupted nighttime sleep.

• Diagnosis is confirmed through specialized sleep studies (PSG and MSLT) that measure sleep patterns and the tendency to fall asleep quickly.

• Treatment is focused on managing symptoms through a combination of lifestyle adjustments, scheduled naps, and medications to improve alertness and control cataplexy.

With proper management, many people with narcolepsy can lead full and productive lives.

Frequently Asked Questions About Narcolepsy

Q1: What is narcolepsy?

A1: Narcolepsy is a chronic neurological sleep disorder that disrupts the central nervous system's ability to control sleep-wake cycles (Maski & Guilleminault, 2022). It is classified as a central disorder of hypersomnolence, meaning it causes persistent and overwhelming daytime sleepiness. The condition is divided into two main types: narcolepsy type 1 (NT1), which includes sudden muscle weakness (cataplexy), and narcolepsy type 2 (NT2), which does not (Mignot, 2022).

Q2: What causes narcolepsy?

A2: The most common form of the disorder, narcolepsy type 1, is caused by the irreversible loss of specific brain cells that produce a chemical called hypocretin (also known as orexin), which is essential for staying awake (Mignot, 2022). This cell loss is believed to be the result of a T-cell-mediated autoimmune attack, where the body's own immune system mistakenly destroys these vital neurons (Mignot, 2022). The exact cause of narcolepsy type 2 is less understood, as individuals with NT2 typically have normal hypocretin levels.

Q3: Is narcolepsy a genetic disorder?

A3: Narcolepsy has a strong genetic component, but genetics alone do not cause it. Approximately 97% of patients with narcolepsy type 1 carry a specific genetic marker known as HLA-DQB1*06:02 (Mignot, 2022). However, many people in the general population have this gene and never develop the disorder. The concordance rate in identical twins is only 25% to 30%, which shows that environmental factors, such as upper airway infections like the H1N1 influenza virus, are necessary to trigger the disease in genetically susceptible individuals (Mignot, 2022).

Q4: What is cataplexy and does everyone with narcolepsy have it?

A4: Cataplexy is a sudden, temporary loss of muscle control that is the defining symptom of narcolepsy type 1. It is typically triggered by strong, positive emotions like laughter or surprise (Maski & Guilleminault, 2022). Not everyone with narcolepsy experiences cataplexy; it is absent in individuals who have narcolepsy type 2.

Q5: How do sleep medicine doctors test for narcolepsy?

A5: Doctors diagnose narcolepsy using a combination of a detailed clinical history and two main sleep studies. The process begins with an overnight polysomnogram (PSG) to rule out other sleep disorders. This is followed by a Multiple Sleep Latency Test (MSLT), which involves a series of scheduled naps to measure how quickly a person falls asleep during the day. A diagnosis is confirmed if the MSLT shows an average sleep onset of 8 minutes or less and at least two instances of entering REM sleep quickly (known as SOREMPs) (Maski & Guilleminault, 2022).

Q6: Can narcolepsy be cured?

A6: No, there is currently no cure for narcolepsy because the loss of hypocretin-producing neurons is considered permanent (Mignot, 2022). However, the condition is manageable. A combination of behavioral strategies, such as scheduled naps, and medications can effectively control symptoms like sleepiness and cataplexy, allowing many individuals to lead active and fulfilling lives (Maski & Guilleminault, 2022).

Q7: Does narcolepsy get worse with age?

A7: No, narcolepsy is not a progressive neurodegenerative disease. Longitudinal studies suggest that daytime sleepiness is often most severe when the illness first begins and may stabilize or even improve slightly with age. Similarly, the frequency and severity of cataplexy attacks generally decrease as patients get older (Mignot, 2022; Maski & Guilleminault, 2022).

References

Maski, K., & Guilleminault, C. (2022). Narcolepsy: Diagnosis and management. In M. Kryger, T. Roth, C. A. Goldstein, & W. C. Dement (Eds.), Principles and practice of sleep medicine (7th ed.). Elsevier.

Maski, K., & Scammell, T. E. (2022). Central disorders of hypersomnolence. In M. Kryger, T. Roth, C. A. Goldstein, & W. C. Dement (Eds.), Principles and practice of sleep medicine (7th ed.). Elsevier.

Mignot, E. (2022). Narcolepsy: Pathophysiology and genetic predisposition. In M. Kryger, T. Roth, C. A. Goldstein, & W. C. Dement (Eds.), Principles and practice of sleep medicine (7th ed.). Elsevier.

Sahni, A. S., & Attarian, H. (2022). Transitional care for adolescents with narcolepsy and other central disorders of hypersomnolence. In M. Kryger, T. Roth, C. A. Goldstein, & W. C. Dement (Eds.), Principles and practice of sleep medicine (7th ed.). Elsevier.

Written By: The Better Sleep Clinic Team
Reviewed By: Dan Ford, DBSM, Sleep Psychologist